Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adriana Bajetto

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Journal of Oncology|January 6, 2010
Role of chemokine network in the development and progression of ovarian cancer: a potential novel pharmacological targetFederica Barbieri, Adriana Bajetto, Tullio Florio
Journal of Neurochemistry|October 2, 2002
Characterization of chemokines and their receptors in the central nervous system: physiopathological implicationsAdriana Bajetto, Rudy Bonavia, Simone Barbero, et al.
Annals of the New York Academy of Sciences|January 22, 2005
CXCR4 activation induces epidermal growth factor receptor transactivation in an ovarian cancer cell lineCarola Porcile, Adriana Bajetto, Simone Barbero, et al.
Expert Opinion on Drug Discovery|September 7, 2016
Drug design strategies focusing on the CXCR4/CXCR7/CXCL12 pathway in leukemia and lymphomaFederica Barbieri, Adriana Bajetto, Stefano Thellung, et al.
International Immunopharmacology|October 16, 2023
Metformin potentiates immunosuppressant activity and adipogenic differentiation of human umbilical cord-mesenchymal stem cellsAdriana Bajetto, Alessandra Pattarozzi, Rodolfo Sirito, et al.
Frontiers in Cellular Neuroscience|June 7, 2014
CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironmentRoberto Würth, Adriana Bajetto, Jeffrey K Harrison, et al.
Expert Opinion on Therapeutic Targets|November 25, 2024
Chemokine signaling in tumors: potential role of CXC chemokines and their receptors as glioblastoma therapeutic targetsAlessandro Corsaro, Beatrice Tremonti, Adriana Bajetto, et al.
Toxicology Letters|March 12, 2003
Chemokines and their receptors in the CNS: expression of CXCL12/SDF-1 and CXCR4 and their role in astrocyte proliferationRudy Bonavia, Adriana Bajetto, Simone Barbero, et al.
Journal of Molecular Endocrinology|March 7, 2007
Role of stromal cell-derived factor 1 (SDF1/CXCL12) in regulating anterior pituitary functionFederica Barbieri, Adriana Bajetto, Carola Porcile, et al.
Drug Discovery Today|October 13, 2015
Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compoundsRoberto Würth, Stefano Thellung, Adriana Bajetto, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Journal of Oncology|January 6, 2010
Role of chemokine network in the development and progression of ovarian cancer: a potential novel pharmacological targetFederica Barbieri, Adriana Bajetto, Tullio Florio
Journal of Neurochemistry|October 2, 2002
Characterization of chemokines and their receptors in the central nervous system: physiopathological implicationsAdriana Bajetto, Rudy Bonavia, Simone Barbero, et al.
Annals of the New York Academy of Sciences|January 22, 2005
CXCR4 activation induces epidermal growth factor receptor transactivation in an ovarian cancer cell lineCarola Porcile, Adriana Bajetto, Simone Barbero, et al.
Expert Opinion on Drug Discovery|September 7, 2016
Drug design strategies focusing on the CXCR4/CXCR7/CXCL12 pathway in leukemia and lymphomaFederica Barbieri, Adriana Bajetto, Stefano Thellung, et al.
International Immunopharmacology|October 16, 2023
Metformin potentiates immunosuppressant activity and adipogenic differentiation of human umbilical cord-mesenchymal stem cellsAdriana Bajetto, Alessandra Pattarozzi, Rodolfo Sirito, et al.
Frontiers in Cellular Neuroscience|June 7, 2014
CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironmentRoberto Würth, Adriana Bajetto, Jeffrey K Harrison, et al.
Expert Opinion on Therapeutic Targets|November 25, 2024
Chemokine signaling in tumors: potential role of CXC chemokines and their receptors as glioblastoma therapeutic targetsAlessandro Corsaro, Beatrice Tremonti, Adriana Bajetto, et al.
Toxicology Letters|March 12, 2003
Chemokines and their receptors in the CNS: expression of CXCL12/SDF-1 and CXCR4 and their role in astrocyte proliferationRudy Bonavia, Adriana Bajetto, Simone Barbero, et al.
Journal of Molecular Endocrinology|March 7, 2007
Role of stromal cell-derived factor 1 (SDF1/CXCL12) in regulating anterior pituitary functionFederica Barbieri, Adriana Bajetto, Carola Porcile, et al.
Drug Discovery Today|October 13, 2015
Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compoundsRoberto Würth, Stefano Thellung, Adriana Bajetto, et al.
Pageof 5